Overall, these results further reinforce the notion of a mixed-type interferonopathy in DS, with key contributions of type II and type III IFN signaling, while also demonstrating that IFN hyperactivity is linked to induction of specific major inflammatory pathways dysregulated in DS, such as TNFα and IL-6 signaling. The gene discussed is IFNA1; the disease is Dravet syndrome.